Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pol

Showing results (211-220 of 221) with videos related to

Pageof 23
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2005
Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: a European case-control studyY Yazdanpanah, G De Carli, B Migueres, et al.
Revue D'Epidemiologie Et De Sante Publique|November 1, 2006
[Risk factors for hepatitis C virus transmission to Health Care Workers after occupational exposure: a European case-control study]Y Yazdanpanah, G De Carli, B Migueres, et al.
Gastroenterologie Clinique Et Biologique|March 26, 2002
[Hepavir, the first observational study of one cohort of patients treated with alpha-2a interferon, monotherapy. Evaluation of asthenia and its social consequences]F Roudot-Thoraval, A Abergel, F Allaert, et al.
Gut|September 18, 2002
Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levelsC Renou, P Halfon, S Pol, et al.
Journal of Viral Hepatitis|May 20, 2003
Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trialT Poynard, P Marcellin, A Bissery, et al.
Alimentary Pharmacology & Therapeutics|October 11, 2017
The negative impact of HBV/HCV coinfection on cirrhosis and its consequencesS Pol, G Haour, H Fontaine, et al.
Gut|September 13, 2014
Impact of common risk factors of fibrosis progression in chronic hepatitis CS Rüeger, P-Y Bochud, J-F Dufour, et al.
Journal of Viral Hepatitis|May 20, 2003
Retreatment with interferon and ribavirin vs interferon alone according to viraemia in interferon responder-relapser hepatitis C patients: a prospective multicentre randomized controlled studyI Portal, M Bourlière, P Halfon, et al.
HIV Medicine|December 8, 2017
Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)E Rosenthal, C Fougerou-Leurent, A Renault, et al.
Journal of Viral Hepatitis|June 30, 2005
Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII StudyC Payan, F Roudot-Thoraval, P Marcellin, et al.
Pageof 23

Showing results (211-220 of 221) with videos related to

Sort By:
Pageof 23
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2005
Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: a European case-control studyY Yazdanpanah, G De Carli, B Migueres, et al.
Revue D'Epidemiologie Et De Sante Publique|November 1, 2006
[Risk factors for hepatitis C virus transmission to Health Care Workers after occupational exposure: a European case-control study]Y Yazdanpanah, G De Carli, B Migueres, et al.
Gastroenterologie Clinique Et Biologique|March 26, 2002
[Hepavir, the first observational study of one cohort of patients treated with alpha-2a interferon, monotherapy. Evaluation of asthenia and its social consequences]F Roudot-Thoraval, A Abergel, F Allaert, et al.
Gut|September 18, 2002
Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levelsC Renou, P Halfon, S Pol, et al.
Journal of Viral Hepatitis|May 20, 2003
Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trialT Poynard, P Marcellin, A Bissery, et al.
Alimentary Pharmacology & Therapeutics|October 11, 2017
The negative impact of HBV/HCV coinfection on cirrhosis and its consequencesS Pol, G Haour, H Fontaine, et al.
Gut|September 13, 2014
Impact of common risk factors of fibrosis progression in chronic hepatitis CS Rüeger, P-Y Bochud, J-F Dufour, et al.
Journal of Viral Hepatitis|May 20, 2003
Retreatment with interferon and ribavirin vs interferon alone according to viraemia in interferon responder-relapser hepatitis C patients: a prospective multicentre randomized controlled studyI Portal, M Bourlière, P Halfon, et al.
HIV Medicine|December 8, 2017
Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)E Rosenthal, C Fougerou-Leurent, A Renault, et al.
Journal of Viral Hepatitis|June 30, 2005
Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII StudyC Payan, F Roudot-Thoraval, P Marcellin, et al.
Pageof 23